Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1294629생성일: 2026년 10월 25일
Stannous chloride dihydrate → 1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-ethylbenzoyl]-piperidine
https://huagongshe.com/reaction/1294629
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Stannous chloride dihydrate | HCID 61436 | — |
| 반응물 | 2,1,3-Benzothiadiazole, 4-chlorosulfonyl- | HCID 2735459 | — |
| 반응물 | (4-Ethyl-2-nitro-phenyl)-piperidin-1-yl-methanone | HCID 16090717 | — |
| 반응물 | 2-Amino-4-ethyl-phenyl-piperidin-1-yl-methanone | HCID 16090737 | — |
| 생성물 | 1-[2-[(2,1,3-Benzothiadiazol-4-ylsulfonyl)amino]-4-ethylbenzoyl]-piperidine | HCID 11396307 | — |
반응 단계
To a stirred solution of 2-nitro-4-vinylbenzoic acid piperidine amide (100 mg, 0.39 mmol) in methanol (15 mL) was added Pd on carbon (10 wt %, 25 mg). The reaction mixture was maintained under ˜1 atm H2 and stirred for 12 h. The mixture was filtered through diatomaceous earth and concentrated in vacuo to yield (4-ethyl-2-nitro-phenyl)-piperidin-1-yl-methanone, which was subsequently reduced to (2-amino-4-ethyl-phenyl)-piperidin-1-yl-methanone with SnCl2.2H2O as described in EXAMPLE 5. The title compound was prepared from the aniline (90 mg, 0.39 mmol) and 4-chlorosulfonyl-2,1,3-benzothiadiazole (181 mg, 0.78 mmol), and purified as described in EXAMPLE 15 TLC (silica gel, 3:1 EtOAc/hexanes): Rf=0.32. MS (ESI): m/z 431 [M+H]+, 453 [M+Na]+. HPLC (reversed-phase): RT=9.52 min (single peak). 1H NMR (400 MHz, CDCl3): (rotameric broadening) 8.95 (s, 1H), 8.21 (m, 2H), 7.65 (dd, J=8.8, 7 Hz, 1H), 7.47 (d, J=1.3 Hz, 1H), 6.95 (d, J=7.8 Hz, 1H), 6.85 (dd, J=7.9, 1.6 Hz, 1H), 3.14 (bs, 4H), 2.60 (m, 2H), 1.61 (m, 2H), 1.43 (bs, 4H), 1.17 (t, J=7.6 Hz, 3H). Elemental analysis: calculated for C20H22N4O3S2, C, 55.79; H, 5.15; N, 13.01; found C, 55.44; H, 5.50; N, 12.62.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07241759B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_07 |
|---|
| ORD ID | ord-3461e8cc8be749c8bd476112515c0ed7 |
|---|
| 출처 메모 | uspto-grants-2007_07 |
|---|